How to appeal a CareFirst BCBS stroke & neuro rehab denial

The framework that applies to your appeal

Federal law gives you the right to a full and fair internal appeal, then an external review by an independent third party.

CareFirst BCBS-specific note: BCBS licensee for Maryland, DC, and northern Virginia (~3.5M members). Operates as non-profit. Appeals jurisdiction depends on policy issue location — MIA (MD), DISB (DC), or SCC Bureau of Insurance (VA). CVS Caremark is the PBM.

What CareFirst BCBS's policy requires for stroke & neuro rehab

Cited policy: BCBS Evidence Positioning System: Robot-Assisted Walking Therapy for Stroke

Most BCBS plans cover post-2018. Lokomat / Indego / EksoNR / NAVIO. Documented gait deficit + IRF or outpatient setting + supervised by trained therapist.

How CareFirst BCBS denies stroke & neuro rehab — and how to counter it

Where CareFirst BCBS pushes back: 1) Experimental; 2) No superior outcome vs conventional gait training; 3) Insufficient evidence.

Counter-arguments that hold up: Lokomat FDA-cleared 2002 — NOT experimental. Indego FDA 2016. EksoNR FDA Apr 2020 stroke indication. LEAPS Duncan NEJM 2011 randomized locomotor training. APTA Clinical Practice Guideline (Hornby JNPT 2020) endorses BWS treadmill training. ASIA + ACRM endorse. Document gait assessments (10MWT + 6MWT) + chronic-phase rationale + therapist robot certification.

What CareFirst BCBS typically denies for stroke & neuro rehab

Across CareFirst BCBS's commercial and Medicare books, denials cluster around a small number of patterns. For stroke & neuro rehab, expect:

• DC/MD/VA cross-jurisdiction issues
• Step therapy on specialty drugs via CVS Caremark
• Behavioral health network adequacy
• BlueChoice HMO referral denials

Treatments most often denied in this category

These are the stroke & neuro rehab treatments most often flagged for prior auth, step therapy, or medical necessity review:

• Acute thrombectomy / tPA
• IRF admission
• LTACH
• SNF sub-acute
• Outpatient PT/OT/SLP
• CIMT

How to submit the appeal to CareFirst BCBS

1. Read the denial letter — note the exact denial reason code and the appeal deadline (180 days from the date on the letter).
2. Gather supporting documentation: physician letter of medical necessity, relevant clinical notes, peer-reviewed citations supporting the treatment for your indication, and the policy or coverage document CareFirst BCBS cited in the denial.
3. File the appeal through CareFirst BCBS's portal (members: https://member.carefirst.com ; providers: https://provider.carefirst.com). Standard decision returns within 30 days; expedited urgent appeals return within 72 hours.
4. If denied again, request external review by an independent reviewer within 4 months of the final internal denial. In MD, the state insurance department coordinates external review for fully-insured plans; ERISA self-funded plans use a federal external review through DOL/EBSA.

Clinician or prior-auth team handling this on the practice side? See CareFirst BCBS's prior-authorization criteria by drug: CareFirst BCBS PA criteria on ApprovalHelp.